Sincalide
Who holds supplier records for Sincalide? 5 organisations hold a current record for Sincalide: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (4); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sincalide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sincalide
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
4 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Sincalide expires 20 Apr 2038. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sincalide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BACHEM AGCompany GMP cert on recordActive DMF 15165 · latest filing Nov 2000
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 34202 · latest filing Dec 2019
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 32302 · latest filing Jan 2018
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 36429 · latest filing Oct 2021
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 40875 · latest filing Jan 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Sincalide are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- BACHEM AMERICAS INCInactive DMF 30431 · filed Mar 2016
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Sincalide). The latest listed patent expires 20 Apr 2038. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Sincalide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1121).
Chemical identity
- IUPAC name
- (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid
- Canonical SMILES
- CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)N
- InChIKey
- IZTQOLKUZKXIRV-YRVFCXMDSA-N
- Synonyms
- Cck-8, Cck-8s, Cck c-terminal octapeptide, Cholecystokinin c-terminal octapeptide, Kinevac, Sincalida, Sincalide, SQ 19844, SQ-19844, Sincalidum, Syncalide, Cholecystokinin octapeptide
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholecystokinin Analog
- Chemical structure
- Cholecystokinin
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sincalide?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Sincalide: BACHEM AG, BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Sincalide Drug Master Files are active?
BACHEM AG (DMF 15165), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 34202), MATRIX PHARMACORP PRIVATE LTD (DMF 32302), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 36429) and Sun Pharmaceutical Industries Limited (DMF 40875). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Sincalide records mean?
1 organisation has only inactive Type II DMFs for Sincalide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Sincalide?
Yes. The latest patent listed for an approved US product containing Sincalide expires 20 Apr 2038, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Sincalide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sincalide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.